Top Medical News

Endovascular Treatment Delays Associated Losses in Healthy Life-Years

May 14, 2021

By Marco Meglio

Among early-treated patients, in the door-to-puncture time interval, each 1 hour of delay was associated with 0.92 health life-years lost and each 1 second of delay with 2.2 health life-hours lost.

Recombinant Factor Vlla to be Studied as Intracerebral Hemorrhage Treatment

May 13, 2021

By Victoria Johnson

Northwell Health will conduct a NIH-funded study assessing the effects of the experimental drug in treating patients with ICH.

Encouraging OSA Testing and Awareness Among Physicians

May 13, 2021

By Victoria Johnson

William Noah, MD, director and founder of the Sleep Centers of Middle Tennessee, discussed the aim of his practice’s study.

B-Cell Depletion a Factor in SARS-CoV-2 Antibody Response in Multiple Sclerosis

May 13, 2021

By Marco Meglio

All patients treated with ocrelizumab (Ocrevus; Genentech) were B-cell depleted and had lower SARS-CoV-2 antibody response than any other patients in the study.

scAAV9 Gene Therapy Safe, Effective in Preclinical Study in Epileptic SLC13A5 Deficiency

May 13, 2021

By Marco Meglio

The safety profile of the SLC13A5 vector was “excellent” according to study authors, with no adverse effects on weight, general activity, or survival in knockout mice and wild type littermates.

Featured

Episode 36: Zavegepant and the Gepant Class for Migraine Care

"Mind Moments," a podcast from NeurologyLive, brings you an exclusive interview with Elyse Stock, MD, and Thomas Shoivitz, MD.

NeuroVoices: Vineet Punia, MD, MS, on Responsive Neurostimulation in Older Adults

The neurologist from Cleveland Clinic discussed his study presented at AAN 2021 involving the use of responsive neurostimulation in older adults with drug-resistant focal epilepsy and further expanding research in this space.

Coverage of the 2021 American Academy of Neurology Annual Meeting

All the latest news and updates that the Annual Meeting offers on scientific breakthroughs and cutting-edge therapeutics in neurology, straight from the virtual conference floor.

Disease Spotlight: Migraine

Explore NeurologyLive's coverage of the news and updates on the clinical care of patients with migraine, including interviews with experts in the field and the latest FDA actions.

Disease Spotlight: Multiple Sclerosis

Explore NeurologyLive's coverage of the news and updates on the clinical care of patients with multiple sclerosis, including interviews with experts in the field and the latest FDA actions.

Latest Videos

Overview of Duchenne Muscular Dystrophy (DMD)

Strategies in Treating Relapsing-Remitting Multiple Sclerosis

Treating Epilepsy: Key Takeaways From AES 2020

Lower Sodium Oxybate for Excessive Sleepiness, Narcolepsy, and Hypersomnia: Nancy Foldvary-Schaefer, DO, MS

Improving Progressive MS Research: Kathy Zackowski, PhD, OTR

Regulatory Outlook for Atogepant in Migraine: Lawrence Severt, MD, PhD

Understanding Disparities in Stroke Care: Sana Somani, MD, MBBS

Leaving a Nebulous State of Care for Patients With NMOSD: Bruce Cree, MD, PhD

Better Defining Multiple Sclerosis Categorization: Daniel Ontaneda, MD, PhD

Improving Stroke Discharge Outcomes: Marian LaMonte, MD, MSN, FAAN

Clinical Utility of Manual Dexterity Test in MS: Marisa McGinley, DO

Patient Conversations About Clinical Development in ALS: Matthew B. Harms, MD

The Impact of Big Data on ALS Care: Matthew B. Harms, MD

Most Recent

Study Identifies High Number of Comorbidities in Patients With Migraine

May 12, 2021

Article

In addition to comorbidity frequency, the researchers also studied the comparison of comorbidities between men and women with migraine.

NeuroVoices: Eric Leuthardt, MD, on the IpsiHand Stroke Rehab System

May 12, 2021

Article

The founder and chief scientific officer of Neurolutions discussed how the company’s newly approved chronic stroke rehabilitation system will provide expanded benefits to post-stroke patients.

Pimavanserin: Hopes for FDA Approval in Dementia-Related Psychosis

May 12, 2021

Article

Clive Ballard, MD, the executive dean at the University of Exeter Medical School, discussed the safety and efficacy profile of pimavanserin (Nuplazid; Acadia Pharmaceuticals).

Late-Life Depression May Forecast Cognitive Impairment in the Elderly

May 12, 2021

Article

A poster presentation at the American Psychiatric Association Virtual Meeting suggests that late-life depression might predict self-reported cognitive complaints.

Biogen and Capsigen Collaborate to Develop New AAV Capsids for CNS, Neuromuscular Disorders

May 11, 2021

Article

The partnership combines Capsigen’s vector engineering with Biogen’s drug pipeline, seeking to develop gene therapies for neuromuscular and central nervous system disorders.

Non-REM Bradycardia and Sleep Seizures May Increase Risk of SUDEP

May 11, 2021

Article

Sleep depth was observed to be an independent predictor of heart rate change following seizure for patients with epilepsy.

The Remaining Necessities for Future Progressive MS Research

May 11, 2021

Article

Kathy Zackowski, PhD, OTR, senior director of patient management, care, and rehabilitation research at the National MS Society discussed her team’s call to action for research.

Investigational C6-17 Reduces Mutant Huntingtin Protein and Improves Motor Performance

May 10, 2021

Article

A recent study showed improvements in animals with mutant huntingtin protein treated with AFFiRiS AG’s investigational monoclonal antibody.

Treatment Improvements for Pediatric-Onset MS Have Reduced Risk of Persistent Disability

May 10, 2021

Article

Improvements in DMTs and management standards appear to have lowered the risk of progression to EDSS scores of 4.0 and 6.0 for those with pediatric-onset disease.

Targeting Chronic Inflammation in Progressive MS

May 10, 2021

Article

Daniel Reich, MD, PhD, senior investigator at the National Institutes of Neurological Disorders and Stroke, spoke about his investigations into the role of microglia in progressive MS.